A health ministry panel of experts on July 31 endorsed the plan for Daiichi Sankyo Co. to begin producing and distributing the vaccine, which creates immunity for the conventional strain of the virus.

Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine Approval would give Japan a home-grown mRNA vaccine of the type that has made up the bulk of its COVID inoculations so far.

Daiichi Sankyo has claimed approval in Japan ... cleared under the Datroway brand name – with Japan's Ministry of Health, Labour and Welfare (MHLW) backing its use for patients with previously ...

Even before the FDA's recent approval of Dato-DXd in breast cancer, analysts predicted sales of the antibody-drug conjugate ...

Just 11 days after AstraZeneca and Daiichi Sankyo gained FDA approval for their ... M.D., trial investigator and UCLA Health Jonsson Comprehensive Cancer Center, said in a release.

Daiichi Sankyo has made a little bit of pharma industry ... virus that selectively kills malignant cells. Japan's Ministry of Health, Labour and Welfare (MHLW) has granted a conditional approval ...

The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU ...

Japan's health ministry said on Friday it agreed to buy 1.4 million doses of Daiichi Sankyo's updated COVID-19 vaccine. The purchase is contingent on approval of the shot formulated for the XBB.1. ...

(RTTNews) - The U.S. Food and Drug Administration approved AstraZeneca (AZN, AZN.L) and Daiichi Sankyo's (DSKYF.PK ... For More Such Health News, visit rttnews.com. The views and opinions ...

(AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK ... Monday's Regular trading at $70.08 up $1.02 or 1.48%. For More Such Health News, visit rttnews.com. The views and opinions expressed herein are ...